Results 121 to 130 of about 62,446 (218)
Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort
Arthritis Care &Research, EarlyView.Objective
JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods
A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...Stefano Di Donato, Marie‐Elise Truchetet, Marco Minerba, Oliver Distler, Juan José Alegre Sancho, Yolanda Braun‐Moscovici, Christina Bergmann, Petros Sfikakis, Jeska K. de Vries‐Bouwstra, Murray Baron, Silvia Bellando‐Randone, Lorenzo Dagna, Christopher P. Denton, Madelon C. Vonk, Vanessa Smith, Ivan Castellvi, Gabriela Riemekasten, Andra Balanescu, Masataka Kuwana, Maria De Santis, Kamal Solanki, Anastas Batalov, Vahan Mukuchyan, Marco Matucci‐Cerinic, Yannick Allanore, Francesco Del Galdo, Michael Hughes, EUSTAR Collaborators +27 morewiley +1 more sourceThe Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process
Arthritis Care &Research, EarlyView.Objective
Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.Kara Irwin, Candace H. Feldman, Claire E. H. Barber, Gabriel Fabreau, Jake Jennings, Scott Patten, Cheryl Barnabe, Inflammatory Arthritis‐Specific ACSC Consensus Process Working Group +7 morewiley +1 more sourceClinical Characteristics and Concordance of Anti‐MDA5 Antibodies: A Multicenter Australian Study
Arthritis Care &Research, EarlyView.Objective
In Australia, anti‐MDA5 antibodies are exclusively tested by a line immunoblot assay (LIA). The clinical concordance of an LIA‐positive anti‐MDA5 result is unclear. We aimed to describe the clinical features and determine the clinical concordance of patients with anti‐MDA5 antibodies. Methods
Electronic records of a multisite cohort (patients Syed B. Ali, Thomas Khoo, Keeran Shivakumar, Adam Caroll, Lauren Hender, Dimitra Beroukas, Kim Griggs, Celina Jin, Theo De Malmanche, Jessica Day, Gabor Major, Vidya Limaye +11 morewiley +1 more sourceIncidence, Risk Factors, and Management of Adverse Events in Contemporary, Real‐World Care of Children With Juvenile Idiopathic Arthritis
Arthritis Care &Research, EarlyView.Objective
We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAEs and SAEs) in children with newly diagnosed juvenile idiopathic arthritis (JIA) in Canada. Methods
We enrolled patients within three months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI ...Bashayer Alnuaimi, Roberta A. Berard, Jean‐Philippe Proulx‐Gauthier, Heinrike Schmeling, Michelle Batthish, Gilles Boire, Adam M. Huber, Dax G. Rumsey, Jaime Guzman, Gaëlle Chédeville, for the Canadian Alliance of Pediatric Rheumatology Investigators, David A. Cabral, Gaëlle Chédeville, Ciaran M. Duffy, Kerstin Gerhold, Jaime Guzman, Linda Hiraki, Adam M. Huber, Heinrike Schmeling, Natalie J. Shiff, Lori B. Tucker, Julie Barsalou, Daniah Basodan, Michelle Batthish, Roberta A. Berard, Lyne Bissonnette, Nicholas Blanchette, Gilles Boire, Roxana Bolaria, Alessandra Bruns, Sarah Campillo, Tania Cellucci, Mercedes Chan, Amieleena Chhabra, Julie Couture, Paul Dancey, Jean‐Jacques De Bruycker, Erkan Demirkaya, Muhammed Dhalla, Molly Dushnicky, Janet Ellsworth, Talal El Tal, Brian M. Feldman, Tommy Gerschman, Liane Heale, Julie Herrington, Kristin M. Houghton, Andrea Human, Clare Hutchinson, Mehul Jariwala, Nicole Johnson, Roman Jurencak, Ronald M. Laxer, Piya Lahiry, Bianca Lang, Claire LeBlanc, Jennifer Lee, Deborah M. Levy, Lillian Lim, Lily S. H. Lim, Elizaveta Limenis, Nadia Luca, Jo‐Anne Marcuz, Jeanine McColl, Tara McGrath, Tamara McMillan, Megan McPherson, Paivi Miettunen, Kimberly Morishita, Honyan Ng, Jonathan Park, Jean‐Philippe Proulx‐Gauthier, Johannes Roth, Evelyn V. Rozenblyum, Dax G. Rumsey, Christian Scott, Rosie Scuccimarri, Gordon Soon, Lynn Spiegel, Rebeka Stevenson, Elizabeth Stringer, Herman Tam, Justine Turmel‐Roy, Shirley M. L. Tse, Marinka Twilt, Ruud H. J. Verstegen, Karen Watanabe Duffy, Kristi Whitney, Stephanie Wong +88 morewiley +1 more sourceReal‐World Effectiveness and Safety of Secukinumab in Giant Cell Arteritis: An Italian Multicenter Cohort Study
Arthritis Care &Research, EarlyView.Objective
The objective of this study was to evaluate the real‐world effectiveness and safety of secukinumab in patients with giant cell arteritis (GCA). Methods
This multicenter retrospective study included patients with GCA who received secukinumab at 14 Italian centers with at least six months of follow‐up.Luca Iorio, Federica Davanzo, Caterina Ricordi, Milena Bond, Ruggiero Mascolo, Jacopo Mora, Alessandro Tomelleri, Angelo Fassio, Francesca Cuzzocrea, Sara Monti, Edoardo Conticini, Fabiola Atzeni, Paolo Delvino, Carlotta Nannini, Augusta Ortolan, Francesco Pollastri, Ester Vivaldelli, Chiara Marvisi, Paola Toniati, Antonio Brucato, Alessandra Milanesi, Francesca Regola, Enrico Tombetti, Lorenzo Dagna, Roberta Ramonda, Christian Dejaco, Luca Quartuccio, Carlo Salvarani, Roberto Padoan +28 morewiley +1 more sourceAn Epigenetic Fate Converter Based on Nuclei‐Targeting Lipid Nanoparticles Drives Neuronal Programming of Stem Cells for Spinal Cord Repair
Advanced Functional Materials, EarlyView.Schematic illustration of LNP‐MPG nuclei‐targeting delivery of HMW‐FGF2 promoting histone acetylation to regulate the fate of DPSCs and treat spinal cord injury. LNPs components include pHMW‐FGF2 plasmid, DSPC, Dlin‐MC3‐DMA, cholesterol, and PEG2000, and are modified with MPG to form HMW‐FGF2@LNP‐MPG (HLM). HLM nuclei‐targets DPSCs to deliver HMW‐FGF2, Heng Zhou, Qiang Qin, Xiqin Li, Hanyu Ding, Chun Xu, Yan He, Qingsong Ye +6 morewiley +1 more sourceAdvancing Human Skin Equivalents: The Crucial Role of Neurovascular Integration
Advanced Healthcare Materials, EarlyView.This review discusses the importance of integrating vascular and peripheral nerve systems into human skin equivalents (HSEs) to better recapitulate native skin physiology. Recent advances in vascularized, innervated, and neurovascularized HSEs are highlighted, together with emerging bioengineering strategies, current challenges, and future ...Hao Wu, Lorenzo Moroni, Nicolas Lebonvallet, Vincent Flacher, Paul Wieringa +4 morewiley +1 more sourceEngineering Antigen Density on M13 Bacteriophage for Personalized Nanovaccine
Advanced Healthcare Materials, EarlyView.Increasing antigen density on the phage capsid impacts phage uptake and antigen cross‐presentation by antigen‐presenting cells, leading to enhanced activation of antitumor CD8+ T cells in the draining lymph nodes. These activated CD8+ T cells subsequently recognize the antigen‐expressing tumors and mediate their specific cytotoxic killing, thereby ...Shengnan Huang, Allison Madow, Jack Rudrum, Huaiyao Peng, Hao Nghi Luu, Peiyan Dong, Jifa Qi, Angela M. Belcher +7 morewiley +1 more sourceOxidized Cellulose Nanofiber Hydrogels for 3D Airway Spheroids and Influenza Infection Modeling
Advanced Healthcare Materials, EarlyView.Schematic diagram illustrating antiviral activity in H3N2‐infected airway spheroids exerted by infusion of MSCs. MSCs infusion effectively reduced H3N2 titers and simultaneously upregulated antiviral gene expression, including MX1, OAS1, and STAT1.Jingyi Tang, Boyu Zheng, Mathias Dimde, Katharina Achazi, Chuanxiong Nie, Nan Ma, Rainer Haag +6 morewiley +1 more source